期刊文献+

细胞膜表达的HLA-G诱导免疫耐受性树突状细胞的产生 被引量:2

Induction of Tolerogenic Dendritic Cells by Membrane-Bound HLA-G In Vitro
下载PDF
导出
摘要 为了探讨体外诱导免疫耐受性树突状细胞(dendritic cell,DC)产生的方法及其机制,利用人HLA-G1真核表达载体转染K562细胞并与DC共培养后,用流式细胞术检测DC表面CD80、CD86、ILT3和ILT4分子表达情况,同时采用氚胸腺嘧啶核苷(3H-TdR)掺入法检测DC对T细胞功能的影响。结果表明,膜表达的HLA-G1分子与树突状细胞作用后,DC表面免疫共刺激分子CD80、CD86表达下调,而抑制性分子ILT3、ILT4表达上调。HLA-G1作用后DC异基因抗原诱导淋巴细胞增殖的活性明显下降。结论:HLA-G1分子可以在体外条件下,下调DC表面免疫共刺激分子水平,促进ILT3、ILT4表达,诱导免疫耐受性树突状细胞产生。 In order to study how to induce tolerogenic dendritic cells in vitro and its mechanism, the K562 cells transduced with HLA-G construct were used to co-culture with DC. Then their related immunological changes, such as membrane molecules CD80, CD86, ILT3 and ILT4 expression levels were detected by flow cytometry. Allogeneic proliferation of peripheral blood mononuclear cells (PBMNC) was detected by mixed lymphocyte reaction. The results showed that CD80 and CD86 expressions on DC were downregulated, while ILT3 and ILT4 expressions were upregulated after co-culturing with K562-HLA-G cells. The DCs were less able to stimulate the allogenic PBMNC. It is concluded that the membrane-bound HLA-G can upregulate expression of inhibitory receptors ILT3 and ILT4, inducing tolerogenic DC in vitro, which may provide a novel strategy for transplant tolerance induction.
出处 《中国实验血液学杂志》 CAS CSCD 2007年第2期369-372,共4页 Journal of Experimental Hematology
基金 国家自然科学基金资助项目 编号30571755
关键词 树突状细胞 HLA—G T淋巴细胞 免疫耐受 dendritic cell HLA-G T lymphocyte immune tolerance
  • 相关文献

参考文献10

  • 1Tabbara IA,Kairouz S,Nahleh Z,et al.Current concepts in allogeneic hematopoietic stem cell transplantation.Anticancer Res,2003; 23:5055 -5067
  • 2Steinman RM,Hawiger D,Nussenzweig MC.Tolerogenic dendritic cells.Annu Rev Immunol,2003; 21:685 -711
  • 3Chang CC,Ciubotariu R,Manavalan JS,et al.Tolerization of dendritic cells by T(S) cells:the crucial role of inhibitory receptors ILT3 and ILT4.Nat Immunol,2002; 3:237 -243
  • 4Lila N,Amrein C,Guillemain R,et al.Human leukocyte antigenG expression after heart transplantation is associated with a reduced incidence of rejection.Circulation,2002; 105:1949-1954
  • 5Manavalan JS,Rossi PC,Vlad G,et al.High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells.Transpl Immunol,2003; 11:245 -258
  • 6Takai T.A Novel Recognition System for MHC Class Ⅰ Molecules Constituted by PIR.Adv Immunol,2005; 88:161-192
  • 7Liang S,Baibakov B,Horuzsko A.HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor.Eur J Immunol,2002; 32:2418 -2426
  • 8Carosella ED,Moreau P,Le Maoult J,et al.HLA-G molecules:from maternal-fetal tolerance to tissue acceptance.Adv Immunol,2003 ;81:199 -252
  • 9Ristich V,Liang S,Zhang W,et al.Tolerization of dendritic cells by HLA-G.Eur J Immunol,2005; 35:1133-1142
  • 10刘四喜,方建培,徐宏贵,陈国华,黄绍良.HLA-E真核表达载体的构建及其在K562细胞中的表达与鉴定[J].中国实验血液学杂志,2005,13(3):464-467. 被引量:2

二级参考文献9

  • 1Llano M, Lee N, Navarro F, et al. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur J Immunol, 1998 , 28 : 2854 - 2863.
  • 2Heinzel AS, Grotzke JE, Lines R.A, et al. HLA-E-dependent presentation of Mtb-derived antigen to human CD8^+ T cells. J Exp Med, 2002, 196:1473-1481.
  • 3Menier C, Saez B, Horejsi V, et al. Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class Ⅰ molecules. Hum Immunol, 2003 , 64 : 315 - 326.
  • 4Paul P, Rouas-Freiss N, Moreau P, et al. HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class Ⅰ genes transcription and protein expression. Hum Immunol, 2000,61 : 1177 - 1195.
  • 5Strong RK, Holmes MA, Li P, et al. HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures,and thermal stabilities. J Biol Chem, 2003 , 278 : 5082-5090.
  • 6Lee N, Goodlett DR, Ishitani A, et al. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class Ⅰ signal sequences. J Immunol, 1998, 160:4951 -4960.
  • 7Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood, 1975 , 45 :321 -334.
  • 8黄培堂译.分子克隆实验指南(第3版)[M].北京:科学出版社,2002.1225.
  • 9赵亮,范丽安.HLA-E cDNA克隆及在LcL721.221细胞的表达[J].免疫学杂志,2001,17(6):403-405. 被引量:2

共引文献1

同被引文献10

  • 1Kubagawa H, Burrows PD, Cooper MD. A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc Natl Acad Sci USA, 1997 ;94:5261 -5266.
  • 2Hayami K, Fukuta D, Nishikawa Y, et al. Molecular cloning of a novel murine cell-surface glycoprotein homologous to killer cell inhibitory receptors. J Biol Chem, 1997 ; 272:7320 -7327.
  • 3Yamashita Y, Ono M, Takai T. Inhibitory and stimulatory functions of paired Ig-like receptor (PIR) family in RBL-2H3 cells. J Immunol, 1998; 161:4042-4047.
  • 4Kubagawa H, Chen CC, Ho LH, et al. Biochemical nature and cellular distribution of the paired immunoglobulin-like receptors, PIR-A and PIR-B. J Exp Med, 1999; 189:309 -318.
  • 5Kappes JC, Wu X, Wakefield JK. Production of trans-lentiviral vector with predictable safety. Methods Mol Med,2003 ;76:449 - 465.
  • 6Bartosch B, Cosset FL. Strategies for retargeted gene delivery using vectors derived from lentiviruses. Curr Gene Ther, 2004 ; 4 :427 -443.
  • 7Breckpot K, Dullaers M, Bonehill A, et al. Lentivirally transduced dendritic cells as a tool for cancer immunotherapy. J Gen Med, 2003 ;5:654 - 667.
  • 8Nakamura A, Kobayashi E, Takai T. Exacerbated graft-versus-host disease in Pirb^-/- mice. Nat Immunol, 2004;5:623 -629.
  • 9Ujike A, Takeda K, Nakamura A, et al. Impaired dendritic cell maturation and increased T ( H ) 2 responses in PIR-B ( -/- ) mice. Nat Immunol, 2002 ;3:542 -548.
  • 10刘峥嵘,黎纬明,张敏,王利,葛超,韩红,邹萍.曲古菌素A对小鼠树突状细胞表面配对免疫球蛋白样受体B表达及细胞功能的影响[J].中国组织工程研究与临床康复,2007,11(46):9309-9312. 被引量:2

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部